Jewish Ethics and Biotech Innovation Clash in Supreme Court's BRCA Gene Case

Should Company Be Permitted to Patent 'Breast Cancer' Gene?

‘My DNA’: Lisa Schlager addresses protesters outside the Supreme Court. Many Jewish women may owe their lives to innovative new tests that uncovered their risk of breast cancer. But they strongly feel companies should not be allowed to patent genes.
courtesy of lisa schlager
‘My DNA’: Lisa Schlager addresses protesters outside the Supreme Court. Many Jewish women may owe their lives to innovative new tests that uncovered their risk of breast cancer. But they strongly feel companies should not be allowed to patent genes.

By Anne Cohen

Published April 18, 2013, issue of April 26, 2013.
  • Print
  • Share Share
  • Single Page

(page 3 of 4)

William A. Haseltine, who is a former CEO of Human Genome Sciences and was one of the first people to file for a patent on a gene, agreed with Caplan. He said patents should be granted only in cases where companies have invented a specific test or method, not simply discovered a gene like Myriad did.

“The variant itself is not an invention, but a discovery,” he said.

Haseltine asserted that the Myriad case is “very different from other uses of genes” in which patents have been granted.

“For example, if you use a gene for gene therapy, you’ve taken it out of its natural context and shown that it can be used for health purposes,” he said. “It depends on how you’re using the invention.”

Eisenberg countered that the top court should consider the impact of the ruling on future research. She pointed out that the purpose of the patent system is to incentivize innovation, which can ironically restrict the ability of others to duplicate that innovation.

“It is surely the case that gene patents promote investments in bioresearch, and it is also the case that they have provided an obstacle to research and certain kinds of testing,” said Eisenberg, who has lectured extensively on the role of intellectual property in biopharmaceutical research.

Amid the legal and ethical arguments, Jewish women are left in the middle.

On the one hand, many may owe their lives to the research that Myriad performed to isolate the BRCA genes. One in 40 Ashkenazi women carries this gene mutation, a much higher percentage than in the general population.

“I feel blessed that I was given this knowledge and ability to be proactive with my health,” Schlager said.

But they also may not accept that a private company should control access to the genes and the lifesaving tests to discover them.

“In some ways I do understand private industry’s desire to protect their investments,” said Schlager, whose organization contributed an amicus brief to the Supreme Court arguing against Myriad. “But at the same time, I have to say that DNA are naturally occurring in nature. It’s a natural part of my body. Myriad didn’t create my DNA.”


The Jewish Daily Forward welcomes reader comments in order to promote thoughtful discussion on issues of importance to the Jewish community. In the interest of maintaining a civil forum, The Jewish Daily Forwardrequires that all commenters be appropriately respectful toward our writers, other commenters and the subjects of the articles. Vigorous debate and reasoned critique are welcome; name-calling and personal invective are not. While we generally do not seek to edit or actively moderate comments, our spam filter prevents most links and certain key words from being posted and The Jewish Daily Forward reserves the right to remove comments for any reason.





Find us on Facebook!
  • It’s over. The tyranny of the straight-haired, button nosed, tan-skinned girl has ended. Jewesses rejoice!
  • It's really, really, really hard to get kicked out of Hebrew school these days.
  • "If Netanyahu re-opens the settlement floodgates, he will recklessly bolster the argument of Hamas that the only language Israel understands is violence."
  • Would an ultra-Orthodox leader do a better job of running the Met Council?
  • So, who won the war — Israel or Hamas?
  • 300 Holocaust survivors spoke out against Israel. Did they play right into Hitler's hands?
  • Ari Folman's new movie 'The Congress' is a brilliant spectacle, an exhilarating visual extravaganza and a slapdash thought experiment. It's also unlike anything Forward critic Ezra Glinter has ever seen. http://jd.fo/d4unE
  • The eggplant is beloved in Israel. So why do Americans keep giving it a bad rap? With this new recipe, Vered Guttman sets out to defend the honor of her favorite vegetable.
  • “KlezKamp has always been a crazy quilt of gay and straight, religious and nonreligious, Jewish and gentile.” Why is the klezmer festival shutting down now?
  • “You can plagiarize the Bible, can’t you?” Jill Sobule says when asked how she went about writing the lyrics for a new 'Yentl' adaptation. “A couple of the songs I completely stole." Share this with the theater-lovers in your life!
  • Will Americans who served in the Israeli army during the Gaza operation face war crimes charges when they get back home?
  • Talk about a fashion faux pas. What was Zara thinking with the concentration camp look?
  • “The Black community was resistant to the Jewish community coming into the neighborhood — at first.” Watch this video about how a group of gardeners is rebuilding trust between African-Americans and Jews in Detroit.
  • "I am a Jewish woman married to a non-Jewish man who was raised Catholic, but now considers himself a “common-law Jew.” We are raising our two young children as Jews. My husband's parents are still semi-practicing Catholics. When we go over to either of their homes, they bow their heads, often hold hands, and say grace before meals. This is an especially awkward time for me, as I'm uncomfortable participating in a non-Jewish religious ritual, but don't want his family to think I'm ungrateful. It's becoming especially vexing to me now that my oldest son is 7. What's the best way to handle this situation?" http://jd.fo/b4ucX What would you do?
  • Maybe he was trying to give her a "schtickle of fluoride"...
  • from-cache

Would you like to receive updates about new stories?




















We will not share your e-mail address or other personal information.

Already subscribed? Manage your subscription.